Company Directory / Management Consulting
Public · NASDAQ:CERTFor profitManagement ConsultingRadnor, Pennsylvania, United States
Certara
Certara is a pharmaceutical company that accelerates medicines with biosimulation software and technology.
- Founded
- 2008 18 years ago
- Staff
- 1001-5000 1,376 on LinkedIn
- Followers
- 69k on LinkedIn
- Funding
- $839M as listed, USD
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Set against six million companies
Size
1001-5000 people: larger than 97% of companies with a size listed. 1,376 people list it on LinkedIn.
Age
18 years old.
Reach
Website ranked #612,883 in the world for traffic, about 52k visits a month. 69,461 followers on LinkedIn.
What it does
BiotechnologyHealth CarePharmaceuticalSoftwaremodel-based drug discovery and developmentscientific informaticsPK/PD modeling and simulationPBPK modeling and simulationtrial designdrug developmentregulatory writingquantitative systems pharmacologyclinical pharmacologyquantitative systems toxicologytransparency and disclosuremodel-based meta-analysisregulatory strategyregulatory publishing
Funding, as listed
$839M raised in total
- Rounds5
- LatestGrant, Aug 2023
- Latest amountUSD 5,670,000
- Investors3, 3 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about Certara, field by field. Contact details are held but never shown.
The company
- Name
- Certara
- Type
- For profit
- Status
- Public · NASDAQ:CERT
- Founded
- 2008
- Industry
- Management Consulting
- Categories
- Biotechnology, Health Care, Pharmaceutical, Software
- Specialities
- model-based drug discovery and development, scientific informatics, PK/PD modeling and simulation, PBPK modeling and simulation, trial design, drug development, regulatory writing, quantitative systems pharmacology, clinical pharmacology, quantitative systems toxicology, transparency and disclosure, model-based meta-analysis, regulatory strategy, regulatory publishing
Where
- City
- Radnor
- Region
- Pennsylvania
- Country
- United States
- Markets
- East Coast, Northeastern US
Size and reach
- Staff band
- 1001-5000
- People on LinkedIn
- 1,376
- LinkedIn followers
- 69,461
- Web traffic rank
- #612,883
- Monthly web visits
- 52,296
- Apps
- 1
Funding, as listed
- Total
- $838,500,000 USD
- Rounds
- 5
- Latest round
- Grant
- Latest round date
- Aug 2023
- Latest amount
- 5,670,000 USD
- Investors
- 3
- Lead investors
- 3
- Stock listing
- NASDAQ:CERT
- Listing status
- public
Corporate family
- Acquisitions made
- 13
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Certara reported its first quarter 2024 financial results, indicating a positive financial trend. The company also completed the acquisition of Applied BioMath and launched Simcyp, which are expected to drive further growth. Additionally, Certara relocated to Radnor, PA, and appointed a new Chief Human Resources Officer and General Counsel. However, the company's full year 2023 earnings showed that EPS missed expectations.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Management Consulting in United States.
Graystone StrategyParis · 1-10 peopleCCNH ConsultantsNew Holland · 1-10 people
Five Star DevelopmentParadise Valley · 11-50 people
RootSylvania · 251-500 people · 11k followers
RocketSpaceSan Francisco · 51-100 people · 12k followersNNOMS Global Consultancy Trade Limited CompanyNorth Port · 1-10 peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.